Vago T, Bevilacqua M, Norbiato G
Servizio di Endocrinologia, Ospedale L. Sacco, Milan, Italy.
Arzneimittelforschung. 1995 Oct;45(10):1096-8.
PGHS (cyclooxygenase, prostaglandin endoperoxide synthase, 8.11,14-icosatrienoate hydrogen donor oxygen oxidoreductase, EC 1.14.99.1) is a bifunctional, membrane-bound hemoprotein that catalyzes both the bisoxygenation of arachidonic acid to form PGG2 and the peroxidative reduction of PGG2 to form PGH2. Recently two forms of cyclooxygenase have been isolated, one (COX-1) being "constitutive", the other (COX-2) being mitogen-inducible. Nimesulide (CAS 51803-78-2) has been shown to inhibit with high selectivity COX-2 without affecting COX-1 activity, so explaining the previous observations about the selectivity of the anti-prostaglandin effect of the drug. The potency of the effect, however, seems to be different according to these works. The time dependence of COX-2 inhibitors might afford some clues to a better understanding of the mechanism of COX-2 selective inhibition, on the discrepancy between some authors about the potency of the drug and on the relationship between COX-2 inhibition and inhibition of superoxide anion production, an event also characterized by a time dependence. So we evaluated the time dependency of the effect of nimesulide on COX-1 and COX-2. COX-1 was isolated from ram seminal vesicles, and COX-2 was from sheep placenta. Nimesulide inhibited COX-2 activity in a concentration-dependent manner. The inhibition of COX-2 was characterized by the time dependence, so the IC50 varied according to the time of pre-incubation (from 70 +/- 35 mumol/l to 0.07 +/- 0.05 mumol/l). Nimesulide did not affect COX-1 activity until 1 mumol/l and with an IC50 > 100 mumol/l. In conclusion nimesulide's selective inhibitory effect on COX-2 is time-dependent whereas its weak effect on COX-1 is not time-dependent. This observation agrees with the time dependence effect of COX-2 reported by other workers with NS-398 (N-(2-cyclohexyl-oxy-4-nitrophenyl)methane sulphonamide) and with flosulide and explains the different values of IC50 reported by other workers. Nimesulide shares with other sulfanilide-like drugs the time dependence of its selective effect on COX-2.
前列腺素内过氧化物合酶(环氧化酶,前列腺素内过氧化物合酶,8.11,14-二十碳三烯酸氢供体氧氧化还原酶,EC 1.14.99.1)是一种双功能的膜结合血红素蛋白,它既能催化花生四烯酸双加氧生成PGG2,又能催化PGG2的过氧化还原生成PGH2。最近已分离出两种形式的环氧化酶,一种(COX-1)是“组成型”的,另一种(COX-2)是丝裂原诱导型的。尼美舒利(CAS 51803-78-2)已被证明能高度选择性地抑制COX-2,而不影响COX-1的活性,这就解释了先前关于该药物抗前列腺素作用选择性的观察结果。然而,根据这些研究,其作用效力似乎有所不同。COX-2抑制剂的时间依赖性可能为更好地理解COX-2选择性抑制机制、一些作者关于该药物效力的差异以及COX-2抑制与超氧阴离子产生抑制之间的关系(这一事件也具有时间依赖性)提供一些线索。因此,我们评估了尼美舒利对COX-1和COX-2作用的时间依赖性。COX-1从公羊精囊中分离得到,COX-2从绵羊胎盘中分离得到。尼美舒利以浓度依赖性方式抑制COX-2活性。COX-2的抑制具有时间依赖性,因此IC50根据预孵育时间而变化(从70±35μmol/L到0.07±0.05μmol/L)。尼美舒利在浓度达到1μmol/L之前不影响COX-1活性,其IC50>100μmol/L。总之,尼美舒利对COX-2的选择性抑制作用是时间依赖性的,而其对COX-1的微弱作用不是时间依赖性的。这一观察结果与其他研究人员用NS-398(N-(2-环己氧基-4-硝基苯基)甲磺酰胺)和氟舒利报道的COX-2的时间依赖性效应一致,并解释了其他研究人员报道的不同IC50值。尼美舒利与其他磺胺类药物一样,对COX-2的选择性作用具有时间依赖性。